Comprehensive access support
Janssen is dedicated to making XARELTO® affordable and accessible for all patients. With widespread inclusion on hospital, managed care, and PBM formularies, >95% of commercial and Medicare patients are covered at the lowest branded co-pay.1
To see the coverage for your patients, enter your ZIP code. Your results will appear below.
Tier 2: For most plans, brand-name drugs that are generally covered at lower co-payments than Tier 3 brand-name drugs. (Tier 1 drugs generally are generic drugs and have the lowest co-payments.)
Preferred: For most plans, brand-name drugs that are generally covered at “preferred” or lower co-payments than Tier 3 brand-name drugs. (Tier 1 drugs generally are generic drugs and have the lowest co-payments.)
Tier 3 Preferred: For the plans listed, brand-name drugs that are generally covered at lower co-payments than higher tier brand-name drugs. (Tiers 1 and 2 are reserved for generic drugs.)
Tier 3: For most plans, brand-name drugs that are generally covered at higher co-payments than Tier 2 brand-name drugs.
Tier 4: For most plans, brand-name drugs that are generally covered at higher co-payments than Tier 2 and Tier 3 brand-name drugs.
Covered: For most plans, reimbursable, but at a higher co-payment than the preferred formulary product.
PA: Prior Authorization is required.
ST: Step therapy is required.
The information provided represents no statement, promise, or guarantee by Janssen Pharmaceuticals, Inc., concerning coverage, levels of reimbursement, payment, or charge. Nothing herein may be construed as an endorsement, approval, recommendation, representation, or warranty of any kind. This communication is solely the responsibility of Janssen Pharmaceuticals, Inc. Please consult your payer organization with regard to local or actual coverage, and reimbursement policies and determination processes.
All information is subject to change. Data last updated 12/1/16.
Janssen CarePath Savings Program for XARELTO®
Eligible patients with an approved chronic indication for XARELTO®
(10 mg, 15 mg or 20 mg)
Eligible commercially insured patients can have as little as a $10 co-pay per month for their XARELTO® medication costs with up to $3,400 maximum program benefit per calendar year. Subject to a monthly limit. Not valid for patients using Medicare, Medicare Part D, Medicaid, or other government-funded program.
For eligibility requirements, visit Janssen CarePath or call 877-CarePath (877-227-3728).
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, nonprofit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies. To see if they might qualify for assistance, please have your patient contact a JJPAF program specialist at 1-800-652-6227 (9 am to 6 pm ET) or visit the foundation website at www.jjpaf.org.